NeuroPace (NPCE) Research & Development (2020 - 2026)

NeuroPace's Research & Development history runs 7 years deep, the most recent figure standing at $7.2 million for Q1 2026.

• On a quarterly basis, Research & Development fell 3.37% year-over-year to $7.2 million in Q1 2026; TTM through Mar 2026 was $37.6 million, a 78.39% increase from a year earlier, with the FY2025 full-year figure at $46.6 million, up 96.93% from the prior year.
• Research & Development slipped to $7.2 million in Q1 2026 per NPCE's latest filing, from $10.9 million in the prior quarter.
• Across five years, Research & Development topped out at $12.6 million in Q3 2025 and bottomed at -$6.1 million in Q4 2024.
• The 5-year median for Research & Development is $5.7 million (2022), against an average of $6.3 million.
• Across the five-year window, Research & Development tumbled 212.8% in 2024 and soared 280.31% in 2025, its largest moves.
• Year by year, Research & Development stood at $5.1 million in 2022, then gained by 5.66% to $5.4 million in 2023, then tumbled by 212.8% to -$6.1 million in 2024, then surged by 280.31% to $10.9 million in 2025, then tumbled by 34.26% to $7.2 million in 2026.
• Per Business Quant, the three latest NPCE Research & Development figures stand at $7.2 million (Q1 2026), $10.9 million (Q4 2025), and $12.6 million (Q3 2025).